Literature DB >> 15118444

The outcome of detrusor myotomy in children with neurogenic bladder dysfunction.

Yazan F Rawashdeh1, Troels M Jørgensen, Lars H Olsen, Jens C Djurhuus.   

Abstract

PURPOSE: We evaluate the outcome of detrusor myotomy for neurogenic bladder dysfunction (NBD) in children.
MATERIALS AND METHODS: A retrospective analysis was performed of data compiled from medical and urodynamic records of children younger than 16 years with NBD who had undergone detrusor myotomy from 1992 to 2000 at our department.
RESULTS: Surgery was performed in 14 children with a mean age +/- SD of 6.7 +/- 4.3 years (range 0.9 to 14.2) and mean followup of 5.9 +/- 1.7 years. All patients were diagnosed with NBD, which was the result of myelomeningocele in 9, sacral agenesis in 2, lumbosacral lipoma in 1, multiple vertebral anomalies in 1 and spinal neuroblastoma in 1. Main indications for surgery included urinary incontinence in 11 cases and high pressure/low capacity bladders with vesicoureteral reflux and impending renal damage in 8. No major postoperative complications were recorded. Although mean maximal cystometric bladder capacity was unchanged 1 month postoperatively (89.7 +/- 70.6 ml) compared to preoperatively (92.5 +/- 75.1 ml, p = 0.87), significant increments of 216%, 237% and 292% were measurable at 3 months, 1 year and 5 years, respectively. Ultimately most of the patients approached age specific capacities. Complete continence on clean intermittent catheterization was achieved by 8 of 11 patients and improved markedly in 1. Reflux was alleviated in 6 cases and improved in 1. Kidney function developed normally in all but 1 patient with persistent reflux.
CONCLUSIONS: When feasible, detrusor myotomy offers a safe and effective alternative for the management of pharmacologically intractable NBD in children.

Entities:  

Mesh:

Year:  2004        PMID: 15118444     DOI: 10.1097/01.ju.0000110793.73623.c1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

Review 1.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

2.  Urodynamic profile in myelopathies: A follow-up study.

Authors:  Anupam Gupta; Arun B Taly; Abhishek Srivastava; Murali Thyloth
Journal:  Ann Indian Acad Neurol       Date:  2009-01       Impact factor: 1.383

Review 3.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

4.  Treatment outcome of neurogenic bladder dysfunction in children; a five-year experience.

Authors:  Fathollah Roshanzamir; Mohsen Rouzrokh; Alireza Mirshemirani; Ahmad Khaleghnejad; Leila Mohajerzadeh; Reza Dalirani
Journal:  Iran J Pediatr       Date:  2014-06       Impact factor: 0.364

Review 5.  Augmentation cystoplasty in neurogenic bladder.

Authors:  Bülent Çetinel; Ervin Kocjancic; Çetin Demirdağ
Journal:  Investig Clin Urol       Date:  2016-08-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.